Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia.
Saved in:
| Title: | Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia. |
|---|---|
| Authors: | Winters AC; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado., Maloney KW; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado., Treece AL; Department of Pathology, Children's Hospital Colorado, Aurora, Colorado., Gore L; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado., Franklin AK; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Oct; Vol. 67 (10), pp. e28398. Date of Electronic Publication: 2020 Jul 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
